胺碘酮治疗充血性心力衰竭室性心律失常

目的了解胺碘酮对充血性心力衰竭（congestive heart failure，CHF）并发室性心律失常（ventricular arrhythmia，VA）的疗效，并分析充血性心力衰竭心功能级别与室性心律失常的关系。方法选择心内科住院治疗的病人58例为研究对象，分为胺碘酮组和对照组。结果①心功能越差，复杂性心律失常的发生率越高。②胺碘酮组对心律失常治疗的有效率为93％，对照组为50％，差异有统计学意义（x^2=10．355，P=0．006）；两组病人心功能参数各指标的差值无统计学意义（P〈0．05）；胺碘酮组与对照组对心力衰竭的疗效差异无统计学意义（x^2=4．047，P=0．132）。结论胺碘酮对CHF并VA病人疗效好且安全，值得在临床上推广。

Analysis on the Treating Effect of Sirolimus-eluting Stent on Acute Cardiac Muscle Infarct Patients

Objective: To summarize the effect of sirolimus-eluting stent (SES) on acute cardiac muscle infarct(AMI) patients. Methods: Data of 128 AMI patients who were treated with SES during January 2005 to January 2007 were analysis retrospectively. Results: All stents were planted successfully. There was no acute cardic event occurred during the operation and no death during the patients in hospital. All patients were followed up for 1 years. There were no death and no restraitness occurred. Conclusions: SES is a safe and efficiency methods for the AMI patients.